Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24

Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24

FromCNBC's "Fast Money"


Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24

FromCNBC's "Fast Money"

ratings:
Length:
44 minutes
Released:
Jun 24, 2024
Format:
Podcast episode

Description

Nvidia notching another day of losses, but the broader markets aren’t taking it too hard. How investors are handling the semi slide. Plus A big jump for one biopharma stock as Alnylam delivers promising new heart drug results. What the CEO had to say about the data, and the impact it could have on the space. Fast Money Disclaimer
Released:
Jun 24, 2024
Format:
Podcast episode

Titles in the series (100)

Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.